EVOFEM BIOSCIENCES, INC. Payments of Financing Costs
EVOFEM BIOSCIENCES, INC. (EVFM) reported Payments of Financing Costs of $1.20 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2023-11-14
- EVOFEM BIOSCIENCES, INC. payments of financing costs for the quarter ending 2022-12-31 was $0.00.
- EVOFEM BIOSCIENCES, INC. payments of financing costs for the quarter ending 2022-09-30 was $343.00K.
- EVOFEM BIOSCIENCES, INC. payments of financing costs for the quarter ending 2022-06-30 was $508.00K.
- EVOFEM BIOSCIENCES, INC. payments of financing costs for the quarter ending 2022-03-31 was $351.00K.
- EVOFEM BIOSCIENCES, INC. payments of financing costs for fiscal 2022 was $1.20M, a 23.92% increase from fiscal 2021.
- EVOFEM BIOSCIENCES, INC. payments of financing costs for fiscal 2021 was $970.00K, a 8.49% decline from fiscal 2020.
- EVOFEM BIOSCIENCES, INC. payments of financing costs for fiscal 2020 was $1.06M, a 17.57% decline from fiscal 2019.
- EVOFEM BIOSCIENCES, INC. payments of financing costs for fiscal 2019 was $1.29M, a 9.31% decline from fiscal 2018.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-27 | $343.00K derived: sum of 2 quarters · filed 2023-11-14 | $851.00K derived: sum of 3 quarters · filed 2023-11-14 | $1.20M 10-K · filed 2023-04-27 |
| 2022-09-30 | $343.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $851.00K derived: sum of 2 quarters · filed 2023-11-14 | $1.20M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $508.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $859.00K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $351.00K 10-Q · filed 2023-06-16 | |||
| 2021-12-31 | $970.00K 10-K · filed 2023-04-27 | |||
| 2020-12-31 | $1.06M 10-K · filed 2022-03-10 | |||
| 2019-12-31 | $1.29M 10-K · filed 2021-03-04 | |||
| 2018-12-31 | $1.42M 10-K · filed 2020-03-12 |